Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × S 1 (combination) × Clear all

NCT05026905 2026-01-20

A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic Cancer

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT03443492 2025-12-30

Pancreas

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT06584227 2025-12-08

ACPC

Phase 2 Recruiting

Gastrointestinal

Pancreatic cancer, adult, Pancreatic Neoplasms

NCT00651742 2024-09-19

Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer

Phase 2 Completed

28 enrolled 16 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00652054 2024-09-03

Phase 2 Study of S-1 as 2nd Line Therapy in Metastatic Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT05048524 2024-03-27

Peri-operative SLOG for Localized Pancreatic Cancer

Phase 2 Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06166589 2023-12-12

Second-line Zimberelimab and SIRIOX Chemotherapy for Patient With Previously AG Chemotherapy Treated Pancreatic Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT05138159 2021-11-30

A Study of Donafenib Plus S-1 in Treating Patients With Metastatic Pancreatic Cancer After Chemotherapy With Nab-paclitaxel Plus Gemcitabine Regimen

Phase 2 Unknown

Gastrointestinal

Pancreatic Neoplasms

NCT04808687 2021-03-22

Neoadjuvant Nab-Paclitaxel and S-1 in Resectable Pancreatic Cancer

Phase 2 Unknown

Gastrointestinal

Pancreatic Neoplasms

NCT03986294 2021-01-15

NAPAN

Phase 2 Unknown

Gastrointestinal

Pancreatic Neoplasms

NCT03585062 2021-01-08

Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic Cancer

Phase 2 Terminated

Gastrointestinal

Pancreatic Neoplasms

NCT02459652 2020-10-27

Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT00429858 2020-09-18

Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Phase 2 Terminated

21 enrolled 8 charts

Gastrointestinal

Pancreatic Neoplasms

NCT04377048 2020-05-06

Nivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic Cancer

Phase 2 Unknown

Gastrointestinal

Pancreatic Neoplasms

NCT03825328 2019-01-31

A Trial of NS/GEMOX Chemotherapy in Patients With Untreated Pancreatic Cancer ( HZ-NS/GEMOX-PC )

Phase 2 Unknown

Gastrointestinal

Pancreatic Neoplasms

NCT03636308 2018-08-17

ASAGPAC

Phase 2 Unknown

Gastrointestinal

Pancreatic Neoplasms

NCT01430052 2017-11-21

Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT01693419 2017-08-23

S-1, Gemcitabine and Erlotinib for Advanced Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT02634502 2015-12-18

Radiofrequency Ablation Combined With S-1 for Pancreatic Cancer With Liver Metastasis

Phase 2 Unknown

Gastrointestinal

Pancreatic Neoplasms

NCT01074996 2014-01-16

APC-S1

Phase 2 Unknown

Gastrointestinal

Pancreatic Neoplasms

NCT00514163 2011-06-28

GEM vs GEM+TS-1 for Advanced Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT00197431 2006-03-22

Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer

Phase 2 Unknown

Gastrointestinal

Colonic Neoplasms, Esophageal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms